Sign up to save your podcasts
Or
Share Retatrutide: The Hot New Trend in Weightloss
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Retatrutide: The Hot New Trend in Weightloss
On today’s episode we discuss the latest hot topic in the fitness industry - weight loss drug, Retatrutide.
What are the benefits? Are there potential side effects? What does this mean for bikini competitors in prep, dieting hard for a show?
Follow us on IG
@preplifepodcast
@glamgirlbikini
@amyehinger
@leemarie183
Watch on YouTube: Glam Girl Bikini
Join the team: https://www.glamgirlbi...
1st Phorm Supplements we use:
https://1stphorm.com/?...
Key references
• Jastreboff AM, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity. N Engl J Med / related publications (phase-2 reports).
• Sanyal AJ, et al. Retatrutide and liver fat/liver outcomes. Nature Medicine 2024.
• Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP). N Engl J Med 2021.
• Jastreboff AM, et al. Tirzepatide once weekly for obesity (SURMOUNT) and related reports. PubMed/NEJM/SURMOUNT analyses.
• Conceição-Furber E, et al. Is glucagon receptor activation the thermogenic solution? Frontiers in Endocrinology, review of GCGR and energy expenditure mechanisms.
• Frampton J, et al. The acute effect of glucagon on components of energy expenditure. Int J Obes / Nature Metabolism meta-
View all episodes
By Glam Girl Bikini
4.9
259259 ratings
On today’s episode we discuss the latest hot topic in the fitness industry - weight loss drug, Retatrutide.
What are the benefits? Are there potential side effects? What does this mean for bikini competitors in prep, dieting hard for a show?
Follow us on IG
@preplifepodcast
@glamgirlbikini
@amyehinger
@leemarie183
Watch on YouTube: Glam Girl Bikini
Join the team: https://www.glamgirlbi...
1st Phorm Supplements we use:
https://1stphorm.com/?...
Key references
• Jastreboff AM, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity. N Engl J Med / related publications (phase-2 reports).
• Sanyal AJ, et al. Retatrutide and liver fat/liver outcomes. Nature Medicine 2024.
• Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP). N Engl J Med 2021.
• Jastreboff AM, et al. Tirzepatide once weekly for obesity (SURMOUNT) and related reports. PubMed/NEJM/SURMOUNT analyses.
• Conceição-Furber E, et al. Is glucagon receptor activation the thermogenic solution? Frontiers in Endocrinology, review of GCGR and energy expenditure mechanisms.
• Frampton J, et al. The acute effect of glucagon on components of energy expenditure. Int J Obes / Nature Metabolism meta-
More shows like Prep Life
View all
Muscle Science for Women
463 Listeners
Choose Hard with Cody McBroom
782 Listeners
Confessions of a Bikini Pro
321 Listeners
Beyond the Bikini Radio
192 Listeners
Mind Over Macros
1,126 Listeners
The Bikini and the Brain
398 Listeners
The ProPhysique Code
143 Listeners
The Girl Gainz Podcast
60 Listeners
Know Your Power
212 Listeners
The Macro Hour
581 Listeners
BEcoming RELENTLESS
50 Listeners
FitBody Lifestyle
46 Listeners
Bikinis After Babies
18 Listeners
Self-Selecting
38 Listeners
Bikini Besties Podcast
3 Listeners